Repros in the News

All Releases

View Summary Repros Therapeutics Announces Settlement with Major Creditors

Oct 30, 2009

PDF 14.1 KB Add to Briefcase
View Summary Repros Therapeutics Announces Amendment of NIH Proellex® License

Oct 28, 2009

PDF 13.1 KB Add to Briefcase
View Summary Repros Therapeutics Inc. Announces Financing

Oct 8, 2009

PDF 12.4 KB Add to Briefcase
View Summary REPROS REPORTS ANDROXAL® RESTORES NORMAL SPERM COUNTS WHILE INCREASING TESTOSTERONE LEVELS IN HYPOGONADAL MEN

Oct 6, 2009

PDF 16.8 KB Add to Briefcase
View Summary Repros Therapeutics Inc. Provides Update on Proellex®

Sep 29, 2009

PDF 15.3 KB Add to Briefcase
View Summary Repros Therapeutics Inc. Receives Additional NASDAQ Delisting Notice

Sep 21, 2009

PDF 12.2 KB Add to Briefcase
View Summary Repros Therapeutics Inc. Announces Financing

Sep 8, 2009

PDF 12.1 KB Add to Briefcase
View Summary Repros Therapeutics Inc. Reports Second Quarter 2009 Financial Results and Provides Update

Aug 17, 2009

PDF 75.7 KB Add to Briefcase
View Summary REPROS ANNOUNCES CLASS ACTION LAWSUIT FILED AGAINST IT AND CERTAIN OF ITS OFFICERS AND DIRECTORS, and ALSO ANNOUNCES RECEIPT of NOTICE from NASDAQ of NON-COMPLIANCE with LISTING STANDARDS

Aug 11, 2009

PDF 12.3 KB Add to Briefcase
View Summary Repros Therapeutics Inc. Announces That United States Food and Drug Administration Places Proellex® On Clinical Hold

Aug 6, 2009

PDF 12.0 KB Add to Briefcase
Showing 181-190 of 190 Page: 1 ... 6 7 8 9 10  Previous 20
Add to Briefcase = add release to Briefcase
2408 Timberloch Place, B-7
The Woodlands, Texas 77380
281-719-3400
281-719-3446 fax